Caxton Associates LLP Zoetis Inc. Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
A detailed history of Caxton Associates LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 5,647 shares of ZTS stock, worth $920,686. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,647Holding current value
$920,686% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
2,110Shares Held
421MCall Options Held
1.98MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA41.6MShares$6.78 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.01 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.23 Billion0.14% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.59 Billion2.42% of portfolio
-
Morgan Stanley New York, NY12.7MShares$2.08 Billion0.15% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $76.3B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...